Bas Bloem receives the Tom Isaacs award 2018. Andel Research Institute and The Cure Parkinson’s Trust awarded Bloem, together with Simon Stott, as scientists who strive to improve the lives of people with Parkinson's.Bas Bloem is the co-founder and medical director of Parkinson Center Nijmegen and co-director of ParkinsonNet. ParkinsonNet provides patients across the Netherlands increased access to Parkinson’s experts via the Internet and in person, making it easier for patients to get the care they need. Currently, ParkinsonNet links together 70 professional networks across the country.
Professor Patrik Brundin, Associate Director of Research at VARI and Tom Isaacs Award judging panellist: "Dr. Bloem is deeply committed to collaborating closely with people with Parkinson’s in all aspects of his work - a fact that was important to Tom and that should be a shining example to us all. Through his efforts with ParkinsonNet, people with Parkinson’s in the Netherlands and a growing number of other countries are able to much more easily access specialised care needed to ensure quality of life."
CambridgeStott is a research associate in the lab of Dr. Roger Barker at Cambridge Center for Brain Repair in the United Kingdom and is an active member of the Parkinson’s Research Advocacy Group. Since 2015, Stott has run Science of Parkinson’s, a website dedicated to translating the complex science behind the disease and new breakthroughs into an accessible, patient-friendly format.
Both recipients are tireless advocates for the Parkinson’s community, whose inclusive work and extensive outreach helps shrink the gap between scientists and patients.
The award will be presented on 27th September at the annual Grand Challenges in Parkinson’s and Rallying to the Challenge meeting in Grand Rapids, Michigan.
Tom IsaacsThe Tom Isaacs award was established in memory of Trust co-founder and champion of the Parkinson’s community Tom Isaacs.
Isaacs passed away in May 2017. In the spirit of his ethos, recipients of the award must have had a significant impact on the lives of people with Parkinson’s and/or involved people with Parkinson’s in a participatory way in their work.
Related news items
Radboud-led collaboration generates innovative candidate drug against malaria19 September 2019
A molecule once designed to cure the skin disease psoriasis appears to be particularly effective against malaria. The antimalarial properties were revealed thanks to one researcher’s inspired hunch when the psoriasis drug discovery programme came to a dead end.read more
Radboud university medical center opens first healthcare AI labs19 September 2019
These are the first two ‘labs’ in the east of the Netherlands that are part of the national Innovation Center for Artificial Intelligence and the first health labs. With these two initiatives, Radboudumc and its partners are investing heavily in the application of AI to health care.read more
Careful prescription of addictive painkillers still necessary19 September 2019
Although the use of opioid painkillers in the Netherlands has risen over the past ten years, it is nowhere near the degree to which they are used in the United States, say Arnt Schellekens and his colleagues in an article published in The Lancet Public Health.read more
Exercising at home has a positive effect on Parkinson's patients19 September 2019
In a large double-blind study, Radboudumc researchers show that patients in the early stages of Parkinson's disease can exercise regularly at home for 6 months.read more